On hypotensive action of some imidazoline derivatives of sulphonamidated aryloxyalkylcarboxylic acids.

New imidazolines derived from sulphonamidated aryloxyalkylcarboxylic acids have been tested for their antihypertensive action and toxicity. The obtained results attest a remarkable biological action, low toxicity and a good absorption in oral administration.